On the other hand, the analysis performed by Madden et al. (2014) found overexpression of PER1 and identified a PER1 variant (rs2289591) associated with glioma risk and, similar to the CLOCK variant described above, it was associated with mortality in high-grade glioma patients [225]. This evidence concerns the gene PER1 and central nervous system cancer.